DR3-Blocking Antibody SL-325 Phase 1 Data Set for June 8 Readout
The readout covers tolerability, receptor occupancy, and immunogenicity endpoints — key signals for a mechanism with po…
The readout covers tolerability, receptor occupancy, and immunogenicity endpoints — key signals for a mechanism with po…
Real-world evidence from a matched Medicare cohort signals a meaningful care-pathway shift for lumbar discogenic pain m…
The oral presentation marks a clinical milestone for polyclonal antibody therapies targeting post-transplant viral comp…
Automated CLIA platforms are reshaping how nutraceutical and functional food efficacy claims are validated at the clini…
An R&D Spotlight planned for late summer is expected to outline next-stage development milestones for the investigation…
Health systems leaning on telehealth infrastructure could accelerate practitioner-channel nutraceutical recommendations…